Appendix G

Institute of Medicine Publications on Vaccines

  • Adverse Effects of Vaccines: Evidence and Causality (2012)
  • Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint (2012)
  • “A Perspective on Vaccines,” President’s Address, Institute of Medicine Annual Meeting, Washington, DC (2011)
  • The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series (2010)
  • The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2009)
  • Live Variola Virus: Considerations for Continuing Research (2009)
  • Priorities for the National Vaccine Plan (2009)
  • Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office (2008)
  • Battling Malaria: Strengthening the U.S. Military Malaria Vaccine Program (2006)
  • John R. La Montagne Memorial Symposium on Pandemic Influenza Research: Meeting Proceedings (2006)
  • The Smallpox Vaccination Program: Public Health in an Age of Terrorism (2005)
  • Vaccine Safety Research, Data Access, and Public Trust (2005)
  • Immunization Safety Review: Influenza Vaccines and Neurological Complications (2004)
  • Immunization Safety Review: Vaccines and Autism (2004)


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 217
Appendix G Institute of Medicine Publications on Vaccines • Adverse Effects of Vaccines: Evidence and Causality (2012) • Ranking Vaccines: A Prioritization Framework: Phase I: Demonstra- tion of Concept and a Software Blueprint (2012) • “A Perspective on Vaccines,” President’s Address, Institute of Medicine Annual Meeting, Washington, DC (2011) • The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series (2010) • The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Sum- mary (2009) • Live Variola Virus: Considerations for Continuing Research (2009) • Priorities for the National Vaccine Plan (2009) • Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office (2008) • Battling Malaria: Strengthening the U.S. Military Malaria Vaccine Pro- gram (2006) • John R. La Montagne Memorial Symposium on Pandemic Influenza Research: Meeting Proceedings (2006) • The Smallpox Vaccination Program: Public Health in an Age of Ter- rorism (2005) • Vaccine Safety Research, Data Access, and Public Trust (2005) • Immunization Safety Review: Influenza Vaccines and Neurological Complications (2004) • Immunization Safety Review: Vaccines and Autism (2004) 217

OCR for page 217
218 THE CHILDHOOD IMMUNIZATION SCHEDULE AND SAFETY • Financing Vaccines in the 21st Century: Assuring Access and Avail- ability (2003) • Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy (2003) • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 1 (2003) • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 2 (2003) • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 3 (2003) • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 4 (2003) • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 5 (2003) • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 6 (2003) • Setting the Course—A Strategic Vision for Immunization. Part 3: Sum- mary of the Los Angeles Workshop (2003) • Setting the Course—A Strategic Vision for Immunization. Part 4: Sum- mary of the Washington, DC, Workshop (2003) • The Anthrax Vaccine: Is It Safe? Does It Work? (2002) • An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Re- search Program (2002) • Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies (2002) • Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (2002) • Immunization Safety Review: Multiple Immunizations and Immune Dysfunction (2002) • Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer (2002) • Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military (2002) • Scientific and Policy Considerations in Developing Smallpox Vaccina- tion Options: A Workshop Report (2002) • Setting the Course—A Strategic Vision for Immunization Finance. Part 1: Summary of the Chicago Workshop (2002) • Setting the Course—A Strategic Vision for Immunization. Part 2: Sum- mary of the Austin Workshop (2002) • Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001) • Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (2001)

OCR for page 217
APPENDIX G 219 • Statement from the IOM Council on Vaccine Development (2001) • An Assessment of the Safety of the Anthrax Vaccine: A Letter Report (2000) • Calling the Shots: Immunization Finance Policies and Practices (2000) • Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Avail- ability: A Letter Report (2000) • Vaccines for the 21st Century: A Tool for Decisionmaking (2000) • Assessment of Future Scientific Needs for Live Variola Virus (1999) • Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices (1999) • Detecting and Responding to Adverse Events Following Vaccination: Workshop Summary (1997) • Research to Identify Risks for Adverse Events Following Vaccination: Biological Mechanisms and Possible Means of Prevention: Workshop Summary (1997) • Risk Communication and Vaccination: Workshop Summary (1997) • Options for Poliomyelitis Vaccination in the United States: Workshop Summary (1996) • Vaccines Against Malaria: Hope in a Gathering Storm (1996) • The Children’s Vaccine Initiative: Continuing Activities (1995) • Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality (1994) • DPT Vaccine and Chronic Nervous System Dysfunction: A New Analy- sis (1994) • Research Strategies for Assessing Adverse Events Associated with Vac- cines: A Workshop Summary (1994) • The Children’s Vaccine Initiative: Achieving the Vision (1993) • Adverse Effects of Pertussis and Rubella Vaccines (1991) • The Potential Value of Research Consortia in the Development of Drugs and Vaccines Against HIV Infection and AIDS (report of a workshop) (1989) • An Evaluation of Poliomyelitis Vaccine: Policy Options (1988) • Prospects for Vaccines Against HIV Infection (1988) • Temperature-Stable Vaccines for Developing Countries: Significance and Development Strategies (1987) • New Vaccine Development: Establishing Priorities. Volume II, Diseases of Importance in Developing Countries (1986) • New Vaccine Development: Establishing Priorities. Volume I, Diseases of Importance in the United States (1985) • Vaccine Supply and Innovation (1985) • Evaluation of Poliomyelitis Vaccines (1977)

OCR for page 217